AbbVie Jumps Over 6% on $10.9 Billion Apogee Acquisition, Bolstering Immunology Pipeline

🟢 AbbVie Jumps Over 6% on $10.9 Billion Apogee Acquisition, Bolstering Immunology Pipeline | MarketDownload | MarketDownload